http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2347619-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7da5c8e8c3e8261efe7e698c7198681b http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b3c6f6ab0b69584e0bba483b29398a7a |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate | 2008-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42a124729f66e6dfc8d42a7c96f503de http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fcd6246fbc33e36599e160644df0370 |
| publicationDate | 2011-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2347619-B1 |
| titleOfInvention | PROCEDURE TO DESIGN AN ANTITUMORAL INDIVIDUAL THERAPY BASED ON THE DETECTION OF HSP90 PROTEIN LEVELS, THE USE OF HSP90 PROTEIN INHIBITORS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS, THE COMPOSITIONS AS OBTAINED AND THEIR APPLICATIONS. |
| abstract | Procedure to design a therapynindividual antitumor based on the detection of levels ofnHSP90 protein, the use of HSP90 protein inhibitors for thenpreparation of pharmaceutical compositions, compositions as wellnobtained and its applications.n n n The present invention describes a processnto design an individual antitumor therapy to a subject basednin the detection of HSP90 protein levels responsible for thenresistance to a medication or a mixture of medicationsnIGF1R / KIT receptor inhibitor antitumor agents. Equally,ndescribes the use of HSP90 protein inhibitors forndevelopment of medicines for the treatment of tumorsnresistant to IGF1R / KIT inhibitors, the compositionsnpharmaceuticals thus obtained and their applications in tumors such asnEwing's sarcoma. |
| priorityDate | 2008-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 173.